TRACON Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$1M
- Investors
-
4
TRACON Pharmaceuticals General Information
Description
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.
Contact Information
Website
www.traconpharma.comCorporate Office
- 4350 La Jolla Village Drive
- Suite 800
- San Diego, CA 92122
- United States
Corporate Office
- 4350 La Jolla Village Drive
- Suite 800
- San Diego, CA 92122
- United States
TRACON Pharmaceuticals Timeline
TRACON Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 22. PIPE | 31-May-2023 | $1M | Completed | Profitable | ||
| 21. PIPE | 10-Mar-2023 | Completed | Profitable | |||
| 20. PIPE | 27-Dec-2022 | Completed | Profitable | |||
| 19. General Corporate Purpose | 02-Sep-2022 | Completed | Profitable | |||
| 18. PIPE | 27-Aug-2020 | Completed | Profitable | |||
| 17. Secondary Transaction - Open Market | 30-Jun-2020 | Completed | Profitable | |||
| 16. Secondary Transaction - Open Market | Completed | Profitable | ||||
| 15. PIPE | 09-Apr-2018 | Completed | Generating Revenue | |||
| 14. Secondary Transaction - Open Market | 06-Apr-2018 | $130M | Completed | Generating Revenue | ||
| 13. Secondary Transaction - Open Market | 15-Mar-2017 | $130M | Completed | Generating Revenue |
TRACON Pharmaceuticals Comparisons
Industry
Financing
Details
TRACON Pharmaceuticals Competitors (7)
One of TRACON Pharmaceuticals’s 7 competitors is Arcus Biosciences, a Formerly VC-backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arcus Biosciences | Formerly VC-backed | Hayward, CA | ||||
| Harmony Biosciences Holdings | Formerly VC-backed | Plymouth Meeting, PA | ||||
| Light Chain Bioscience | Formerly PE-Backed | Geneva, Switzerland | ||||
| viDA Therapeutics | Venture Capital-Backed | Vancouver, Canada | ||||
| iQone | Corporate Backed or Acquired | Versoix, Switzerland |
TRACON Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TRACON Pharmaceuticals Patents
TRACON Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018187158-A1 | Combination therapy of cancer with anti-endoglin antibodies and anti-programmed death receptor agents | Inactive | 07-Apr-2017 | ||
| WO-2018067819-A1 | Compositions and methods for treatment of cancers | Inactive | 06-Oct-2016 | ||
| AU-2015346444-A1 | Anti-endoglin antibodies and uses thereof | Inactive | 12-Nov-2014 | ||
| CA-2966905-A1 | Anti-endoglin antibodies and uses thereof | Inactive | 12-Nov-2014 | ||
| WO-2016077451-A1 | Anti-endoglin antibodies and uses thereof | Inactive | 12-Nov-2014 | C07K16/2896 |
TRACON Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TRACON Pharmaceuticals Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lincoln Park Capital | Asset Manager | Minority | ||
| Opaleye | Hedge Fund | Minority | ||
| 683 Capital Managemen | Corporation | Minority | ||
| Puissance Capital Management | Asset Manager | Minority |
TRACON Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
TRACON Pharmaceuticals FAQs
-
When was TRACON Pharmaceuticals founded?
TRACON Pharmaceuticals was founded in 2004.
-
Where is TRACON Pharmaceuticals headquartered?
TRACON Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of TRACON Pharmaceuticals?
TRACON Pharmaceuticals has 17 total employees.
-
What industry is TRACON Pharmaceuticals in?
TRACON Pharmaceuticals’s primary industry is Drug Discovery.
-
Is TRACON Pharmaceuticals a private or public company?
TRACON Pharmaceuticals is a Private company.
-
What is TRACON Pharmaceuticals’s current revenue?
The current revenue for TRACON Pharmaceuticals is .
-
How much funding has TRACON Pharmaceuticals raised over time?
TRACON Pharmaceuticals has raised $223M.
-
Who are TRACON Pharmaceuticals’s investors?
Lincoln Park Capital, Opaleye, 683 Capital Managemen, and Puissance Capital Management have invested in TRACON Pharmaceuticals.
-
Who are TRACON Pharmaceuticals’s competitors?
Arcus Biosciences, Harmony Biosciences Holdings, Light Chain Bioscience, viDA Therapeutics, and iQone are some of the 7 competitors of TRACON Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
